Global Organs-on-chips Market Analysis
According to Verified Market Intelligence, The Global Organs-On-Chips Market was valued at USD 77.34 billion in 2017 and is projected to reach USD 127.76 billion by 2025, growing at a CAGR of 6.5% from 2018 to 2025.
What is Organs-on-chips?
Organs on chips is defined as a process of combining living cells on a scaffold of natural or synthetic material. This provides huge advantages to the pharmaceutical industry, since these 3D organ structures respond far more like human organs than the 2D tissue samples. Organs on chips technology eliminates time and expense of animal trials in drug development and toxin testing. It has wide range of applications in pharmaceutical & biotechnology companies, academic & research institutes, cosmetics industry and many others. Growing scope of biotechnology tools in pharmaceuticals and ethical issues rising to stop animal testing contributes in growth of organs-on-chips market.
Global Organs-on-chips Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Growing focus on eliminating animal testing from clinical testing procedures, rise in fund availability for research and development, growing technological developments and increasing popularity of organ on chip technology have been driving the Global Organs-on-chips Market. On the other hand, factors such as High cost of technology and Incorporation complications associated with the technology into current workflow systems might hinder the overall growth at a global level.
Verified Market Intelligence narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Organs-on-chips Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Organs-on-chips Market Competitive Landscape
The "Global Organs-on-chips Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such CN Bio Tissues, Mimetas
Insphero, Ascendance Bio, Kirkstall , Hurel , Synvivo , Axosim and Nortis. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Organs-on-chips Market Segmentation, by End user
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Cosmetics Industry
• Other
Global Organs-on-chips Market Segmentation, by Application
• Physiological Model Development
• Drug Discovery
• Toxicology Research
Global Organs-on-chips Market Segmentation, by Offering:
• Products
• Services
Global Organs-on-chips Market Segmentation, by Type
• Liver
• Heart
• Lung
• Kidney
• Other
Global Organs-on-chips Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
Research Methodology of Verified Market Intelligence:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Intelligence.
1 INTRODUCTION OF GLOBAL ORGANS-ON-CHIPS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ORGANS-ON-CHIPS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ORGANS-ON-CHIPS MARKET, BY END USER:
5.1 Overview
5.2 Pharmaceutical & Biotechnology Companies
5.3 Academic & Research Institutes
5.4 Cosmetics Industry
5.5 Other End Users
6 GLOBAL ORGANS-ON-CHIPS MARKET, BY APPLICATION:
6.1 Overview
6.2 Physiological Model Development
6.3 Drug Discovery
6.4 Toxicology Research
7 GLOBAL ORGANS-ON-CHIPS MARKET, BY OFFERING:
7.1 Overview
7.2 Products
7.3 Services
8 GLOBAL ORGANS-ON-CHIPS MARKET, BY TYPE:
8.1 Overview
8.2 Liver
8.3 Heart
8.4 Lung
8.5 Kidney
8.6 Other Organs
9 GLOBAL ORGANS-ON-CHIPS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World
10 GLOBAL ORGANS-ON-CHIPS MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Emulate
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 CN Bio
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.2.5
11.3 Ascendance Bio
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Kirkstall
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Hurel
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Synvivo
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Development
11.7 Axosim
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Development
11.8 Tissuse
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Mimetas
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Insphero
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Nortis
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development
12 Appendix
12.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Telecom and IT |
Pages : 131 |